loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 208025 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Dexcel Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 LANSOPRAZOLE (1)

    filter

    01 DEXCEL (1)

    filter

    01 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL (1)

    filter

    01 15MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Lansoprazole

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, ORALLY DISINTE...
    15MG
    LANSOPRAZOLE
    USA
    208025
    2016-06-07
    OTC
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 208025

    Looking for CTD TGA MCC DOSSIER APPLICATION 208025 1

    19

    Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is LANSOPRAZOLE, with a corresponding application number 208025 and regulatory information .

    proudly manufactured in the

    approval since 2016-06-07

    Dexcel Pharma's LANSOPRAZOLE TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL, medication with 15MG of LANSOPRAZOLE.

    Post Enquiry
    POST ENQUIRY